Top 10 Generic Companies in the World in 2021 by Revenues

Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr. Reddy's Laboratories Ltd, and Lupin Ltd are the top 5 Global Generic Companies in 2021 by revenue. Cumulatively, the top 10 Global Generic Companies generated revenue of $37,454 million, with average revenue growth of 6.97%, the highest revenue was generated by Teva Pharmaceutical Industries Ltd ($16,659 million), followed by Sun Pharmaceutical Industries Ltd ($4,533 million) and Cipla Ltd ($2,593 million). The highest revenue growth was registered by Towa Pharmaceutical Co Ltd (40.33%), followed by Cipla Ltd (11.84%), while Teva Pharmaceutical Industries Ltd reported a decline in its revenues by 4.69%. In terms of the geographical split, 9 out of 10 Global Generic Companies are based in Asia, while 1 is based in North America. They employed a total of 173,859 people in 2021. Israel-based Teva Pharmaceutical Industries Ltd is one of the top Global Generic Companies in 2021 by revenue (FY 2021). It discovers, develops, manufactures, and commercializes generic and specialty medicines. The company provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, dermatology, cancer, women’s health, and other disease conditions. The company reported revenue of $16,659 million and employed 34,713 people. India-based Sun Pharmaceutical Industries Ltd is one of the top Global Generic Companies in 2021 by revenue (FY 2021). The company manufactures and supplies more than 400 generic (branded and non-branded) pharmaceuticals to treat conditions such as diabetes, central nervous system disorders, central vascular system disorders, and respiratory and infectious diseases, and markets these drugs in various dosage forms such as tablets/capsules, semi-solids, liquids, and suppositories. The company reported revenue of $4,533 million with average revenue growth of 2.1%. Sun Pharma classifies its business into three categories namely, Formulations, API, and Others. The company’s Consumer Healthcare (CHC) business division develops and markets over-the-counter (OTC) products in India and employed 38,000 people.